Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study

BACKGROUND: Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis. METHODS: The efficacy and safety of vadadustat, compared with darbepoetin alfa, was determined in a Phase 3 double-blind study in Japanese anemic patients on hemodialysis. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nangaku, Masaomi, Kondo, Kazuoki, Ueta, Kiichiro, Kokado, Yoshimasa, Kaneko, Genki, Matsuda, Hiroki, Kawaguchi, Yutaka, Komatsu, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396402/
https://www.ncbi.nlm.nih.gov/pubmed/33650630
http://dx.doi.org/10.1093/ndt/gfab055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396402/
https://www.ncbi.nlm.nih.gov/pubmed/33650630
http://dx.doi.org/10.1093/ndt/gfab055

Ejemplares similares